Beranda › Serangan Jantung › Connecticut
Uji klinis Serangan Jantung di Connecticut
7 studi untuk Serangan Jantung mencari peserta di lokasi di Connecticut.
Kota di Connecticut
Teks studi resmi (Bahasa Inggris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Greater Hartford Nephrology, LLC, Bloomfield
- Nephrology and Hypertension Associates PC, Middlebury
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Bridgeport Hospital, Bridgeport
- Hartford Hospital, Hartford
- Chase Medical Research LLC, Waterbury
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Gandelman Cardiology, PC, Greenwich
- ClinTrial Hamden, Hamden
- Chase Medical Research LLC, Waterbury
Menerima pesertaFase 3
Usia 50 hingga 105 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07136012Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
- University of Connecticut Health Center, Farmington
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04321512Circulating Markers for Ischemic Heart Disease
- University of Connecticut Health Center, Farmington
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT00762333Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Yale School of Medicine, New Haven
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04774159Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
- ROMTech, Brookfield
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05972070Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.